Filing Details
- Accession Number:
- 0001209191-21-045877
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-07 17:31:29
- Reporting Period:
- 2021-07-06
- Accepted Time:
- 2021-07-07 17:31:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
891024 | Patterson Companies Inc. | PDCO | Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) | 410886515 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591945 | L. Andrea Frohning | 1031 Mendota Heights Road St. Paul MN 55120 | Chief Human Resources Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-07-06 | 77 | $30.28 | 41,482 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,070 | Indirect | By ESOP |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Options | $30.77 | 2031-07-01 | 17,339 | 17,339 | Direct | |
Common Stock | Employee Stock Options | $23.57 | 2030-07-14 | 22,026 | 22,026 | Direct | |
Common Stock | Employee Stock Options | $22.25 | 2029-07-01 | 30,030 | 30,030 | Direct | |
Common Stock | Employee Stock Options | $22.48 | 2021-07-01 | 2028-07-01 | 10,009 | 10,009 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2031-07-01 | 17,339 | 17,339 | Direct |
2030-07-14 | 22,026 | 22,026 | Direct |
2029-07-01 | 30,030 | 30,030 | Direct |
2028-07-01 | 10,009 | 10,009 | Direct |
Footnotes
- The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 31, 2021.
- Includes an aggregate of 14,541 RSUs awarded on 7/1/2018, 7/1/2019, 7/14/2020 and 7/1/2021 to Reporting Person pursuant to the Plan. The RSUs vest contingent upon continued employment as follows: 6,649 units vest 7/1/2022, 2,156 units vest 7/1/2023, 4,243 units vest 7/14/2023 and 1,493 units vest 7/1/2024.
- Includes 12,810 RSU equivalents attributable to the July 1, 2020 determination by the Compensation Committee that the performance criteria for the period of April 27, 2019 through April 25, 2020 applicable to non-derivative performance units issued on July 1, 2019 had been satisfied. Subject to continued employment of the Reporting Person through July 1, 2022, the restricted stock unit equivalents will automatically convert into shares of common stock.
- Represents shares of common stock indirectly held by Reporting Person's Employee Stock Ownership Plan ("ESOP") account through May 21, 2021.
- Stock options granted pursuant to the Plan on 7/1/2021.
- Options are exercisable as follows: 33.3% on 7/1/2022, 33.3% on 7/1/2023 and 33.4% on 7/1/2024.
- Stock options granted pursuant to the Plan on 7/14/2020.
- Options are exercisable as follows: 33.3% on 7/14/2021, 33.3% on 7/14/2022 and 33.4% on 7/14/2023.
- Stock options granted pursuant to the Plan on 7/1/2019.
- Options are exercisable as follows: 33.3% on 7/1/2020, 33.3% on 7/1/2021 and 33.4% on 7/1/2022.
- Stock options granted pursuant to the Plan on 7/1/2018.